49 related articles for article (PubMed ID: 552658)
1. [Double blind study of the effect of alveolar air distribution influenced by RG 033 in chronic bronchitis].
Dal Negro R; Dal Negro-Turco P; Lorenzi E; Serra R; Minette A
Rev Inst Hyg Mines (Hasselt); 1979; 34(3):134-40. PubMed ID: 552658
[TBL] [Abstract][Full Text] [Related]
2. [Clinico-pharmacologic study of a new sustained-release oral salbutamol preparation in patients with obstructive airway disease].
Bauer K; Lorenz PR; Seibel K; Neiss A; Eandi M; Kaik G
Arzneimittelforschung; 1989 Jul; 39(7):801-4. PubMed ID: 2675854
[TBL] [Abstract][Full Text] [Related]
3. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial.
Melillo G; Balzano G; Jodice F; De Felice A; Campisi V; Capone M; Di Filippo A; Foddai G; Franzone JS; Grossi E
Int J Clin Pharmacol Res; 1989; 9(6):397-405. PubMed ID: 2699466
[TBL] [Abstract][Full Text] [Related]
4. Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline.
Tantucci C; Grassi V; Verdecchia P; Cornelli U; Sorbini CA
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):560-4. PubMed ID: 3905630
[TBL] [Abstract][Full Text] [Related]
5. [The long-term effect of nifedipine (control release tablets) in patients with chronic obstructive pulmonary disease and cor pulmonale].
Cheng X; Yao Z; Li Q
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Apr; 20(2):84-7. PubMed ID: 10072830
[TBL] [Abstract][Full Text] [Related]
6. Double-blind comparison of tulobuterol and salbutamol in chronic obstructive pulmonary disease.
Germouty J
Clin Ther; 1986; 8(5):546-53. PubMed ID: 2876775
[TBL] [Abstract][Full Text] [Related]
7. Effect of theophylline in chronic obstructive lung disease.
Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
[TBL] [Abstract][Full Text] [Related]
8. Long-term therapy with sustained-release theophylline.
Myhre KI; Arnulf V; Walstad RA
Pharmatherapeutica; 1985; 4(2):92-7. PubMed ID: 3903782
[TBL] [Abstract][Full Text] [Related]
9. [Theophylline plus salbutamol in chronic bronchial obstruction. The additive effects of combination therapy in comparison with salbutamol monotherapy].
Bossert J; Träger E
Fortschr Med; 1989 Apr; 107(11):255-8. PubMed ID: 2659475
[TBL] [Abstract][Full Text] [Related]
10. Role of corticosteroids in the management of chronic obstructive lung disease: factors predicting response.
Goel A; Suri JC; Aggarwal K
Indian J Chest Dis Allied Sci; 1992; 34(1):11-7. PubMed ID: 1521875
[TBL] [Abstract][Full Text] [Related]
11. Single-dose and steady-state effects of controlled-release salbutamol on drug level and airflow obstruction in patients with asthma.
Tan WC; Chan TB; Ang SM
Singapore Med J; 1992 Aug; 33(4):371-4. PubMed ID: 1411667
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study).
Marchioni CF; Polu JM; Taytard A; Hanard T; Noseda G; Mancini C
Int J Clin Pharmacol Ther; 1995 Nov; 33(11):612-8. PubMed ID: 8688986
[TBL] [Abstract][Full Text] [Related]
13. Effect of theophylline on cortisol plasma concentrations in patients with chronic obstructive pulmonary disease.
Gimeno F; Steenhuis EJ; Jonkman JH
Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):139-43. PubMed ID: 2187001
[TBL] [Abstract][Full Text] [Related]
14. [Steroid response after long-term treatment with oral N-acetylcysteine in patients with chronic obstructive bronchitis].
Evald T; Hansen M; Balsløv S; Brorson-Riis L; Hansen NC; Maltbaek N; Thorshauge H
Ugeskr Laeger; 1989 Nov; 151(46):2076-8. PubMed ID: 2688231
[TBL] [Abstract][Full Text] [Related]
15. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
Baronti A; Grieco A; Vibelli C
Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
[TBL] [Abstract][Full Text] [Related]
16. [Obstructive ventilatory disorders in pulmonary tuberculosis].
Evfim'evskiĭ VP; Adamovich NV; Sokolova TP; Grinenko NV
Probl Tuberk; 1993; (1):14-8. PubMed ID: 8327429
[TBL] [Abstract][Full Text] [Related]
17. [Bronchodilator action and side effects of salbutamol in patients with bronchospasm of the respiratory tract].
Cesco G
Minerva Med; 1976 Apr; 67(17):1151-4. PubMed ID: 1264393
[No Abstract] [Full Text] [Related]
18. [Therapeutic action of salbutamol as compared with orciprenaline in patients with chronic obstructive bronchopneumopathy. Double-blind study].
Vesco R; Sussi GW
Minerva Med; 1976 Apr; 67(17):1155-9. PubMed ID: 772479
[No Abstract] [Full Text] [Related]
19. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
[TBL] [Abstract][Full Text] [Related]
20. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
Fontana G; Cresci F; Lo Sapio P; Panuccio P
Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
